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Abstract: Current pulse oximeter sensors can be challenged in working accurately and continuously 
in situations of reduced periphery perfusion, especially among anaesthetised patients. A novel 
tracheal photoplethysmography (PPG) sensor has been developed in an effort to address the 
limitations of current pulse oximeters. The sensor has been designed to estimate oxygen saturation 
(SpO2) and pulse rate, and has been manufactured on a flexible printed circuit board (PCB) that can 
adhere to a standard endotracheal (ET) tube. A pilot clinical trial was carried out as a feasibility 
study on 10 anaesthetised patients. Good quality PPGs from the trachea were acquired at red and 
infrared wavelengths in all patients. The mean SpO2 reading for the ET tube was 97.1% (SD 1.0%) 
vs. the clinical monitor at 98.7% (SD 0.7%). The mean pulse rate for the ET sensor was 65.4 bpm (SD 
10.0 bpm) vs. the clinical monitor at 64.7 bpm (SD 9.9 bpm). This study supports the hypothesis that 
the human trachea could be a suitable monitoring site of SpO2 and other physiological parameters, 
at times where the periphery circulation might be compromised. 
Keywords: photoplethysmography; sensing endotracheal tube; pulse oximetry; vital signs 
monitoring 
 
1. Introduction 
Pulse oximetry is perhaps the most important development in patient monitoring in the last 
forty years, however its limitations are well known and well documented [1–4]. Despite 
improvements in the accuracy of pulse oximetry brought about by advances in signal processing over 
the last decade or so [5], reliable and dependable SpO2 readings still depend on adequate periphery 
perfusion, especially in anaesthetised patients 
While seldom reported in literature these instances do happen [6]. There is a recognised need 
for improved pulse oximetry performance in some groups of vulnerable patients, especially as 
current coping methods only compromise patient safety and place an unwanted burden on the 
surgical team as they try to restore monitoring. 
To overcome this limitation, Kyriacou et al. described an internally placed reflectance pulse 
oximetry system in 2001 that allowed detailed investigation of SpO2 measurements and the 
photoplethysmography (PPG) signals, from which the SpO2 signals are derived from the oesophageal 
wall [7]. The oesophagus was chosen as a potentially suitable central monitoring site as it is readily 
accessible in most anaesthetised patients and is perfused directly by main arteries. 
An initial clinical study, performed in patients undergoing general anaesthesia showed that 
reliable oesophageal signals could be obtained in all subjects, and that the optical pulse signals were 
significantly larger in amplitude than those obtained from a probe placed on the finger. A follow-on 
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clinical study [8,9] investigated and compared oesophageal and finger PPG signals and SpO2 
measurements in 49 patients undergoing hypothermic cardiothoracic bypass surgery. Measurable 
PPG traces at red and infrared wavelengths were obtained in the oesophagus in all 49 patients. Of 
the 49 patients included in the study, it was found that five patients had one or more periods of at 
least ten consecutive minutes during which the commercial finger pulse oximeter failed to display 
SpO2 values, despite being correctly positioned on the finger. Conversely, the oesophageal pulse 
oximeter operated successfully throughout these periods. 
Internal sensors could offer significant improvements in accuracy and reliability over periphery 
sensors in cases of compromised periphery perfusion. In addition to the oesophagus the wall of the 
trachea is so far an unexplored but readily accessible and highly vascularised tissue bed and offers a 
single central site from which a wide range of clinical variables may be measured. There is also the 
additional advantage that every patient is intubated and sensors could be built directly into the 
endotracheal (ET) tube, thus eliminating the need for additional sensors to be placed such as was the 
case with the oesophagus. This work proposes a new novel and flexible tracheal PPG sensor. The 
design of the sensor and preliminary findings on five patients have been previously reported [10]. 
Initial findings show pulse oximetry and HR readings were in broad agreement. The work presented 
here describes the development and continuing clinical evaluation of the endotracheal PPG sensor. 
2. Materials and Methods 
2.1. The Endotracheal Sensor 
Work previously carried out on designing and constructing flexible reflectance PPG sensors with 
unusual geometry [11,12] was adapted to produce a sensor fit for the purpose of placing in the human 
trachea. A custom, flexible, printed circuit board (PCB) and silicone rubber covering were modelled 
in SolidWorks (Dassault Systèmes, Vélizy-Villacoublay, France). Due to the requirement of the sensor 
having to be attached to current standard endo-tracheal tubes (adult sizes 7 and 8), a compromise 
was made on optical component placement and geometry, most notably the components had to be 
arranged linearly, with the red LED closer to the photo diode. The centre-to-centre distances of the 
red and infrared LED to the photodiode were 7 mm and 13 mm, respectively. Normal reflectance 
sensors utilise a single dual LED package consisting of the 2 wavelengths of interest so that the LEDs 
are equidistant from the detector and usually no further than 5 mm. A photograph of the sensor 
before installation onto the ET tube is shown in Figure 1. Overall dimensions of the sensor, including 
the silicone covering are 435 × 29 × 1.3 mm (L × W × H). 
 
Figure 1. The endotracheal photoplethysmography (PPG) sensor before installation onto the 
endotracheal (ET) tube. 
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The PCB carrying the PPG probe was manufactured on a polyester film with a thickness of 75 
µm (Melinex, DuPont, Midland, MI, USA) with a sensor interface at the distal end incorporating one 
660 nm (red) and one 940 nm (infrared) LED (KP-3216 series LEDs, Kingbright, Taipei, Taiwan) and 
a broad spectrum (400–1100 nm) high sensitivity PIN photo diode (VEMD6010 × 01, Vishay 
Semiconductors, PA, USA). The components were bonded to the PCB with a flexible epoxy resin 
(Light Weld 488-Series, DYMAX, USA) and electrically and thermally insulated with the custom 3D-
modelled, clear, silicone rubber covering (Silpuran 6000, Wacker Chemie, Munich, Germany). The 
circuit board was insulated with UV-cured flexible ink (Electrodag 452SS, Henkel, Düsseldorf, 
Germany) and terminated at the proximal end by a 5-pin connector (Crimpfelx, Nicomatic, France). 
The proposed sensor was designed to be single use, hence following the successful completion 
and technical evaluation of a single prototype sensor a batch of 50 sensors was developed for use in 
the pilot clinical trial. All probes were cleaned, sealed in blister packs and chemically sterilised (ETO 
procedure) by a specialised sterilisation company. The sensors were also put under a bio-burden test 
to check for any harmful pathogens or contaminants. 
2.2. Instrumentation 
PPG instrumentation has been developed [13,14] to drive the active elements of the sensor and 
process the raw signals ready for data storage on a laptop computer. The PPG device, named ZenPPG, 
has the ability to drive multiple physiological sensors and can be customised for nearly any clinical 
trial or in vivo study. The current configuration, chosen for these clinical trials of the endotracheal 
(ET) sensor, incorporates two single PPG ports, each with the capability of driving two LEDs and 
sensing from one photo diode. One port will be used for driving the custom ET sensor, whilst the 
other is designed to drive a commercial probe (Masimo, Irvine, CA, USA) for the purpose of 
comparison of PPGs and signal verification. This is connected to an isolation data-acquisition (DAQ) 
card (National Instruments, Austin, TX, USA) which is in turn connected to a laptop computer 
running the DAQ and data-logging software (LabVIEW, National Instruments, USA). 
The LabVIEW virtual instrument (VI) developed to run ZenPPG acquires data at a rate of 1 kHz, 
and can control the individual brightness of individual LEDs on the attached sensors. Data is saved 
in the form of a text file, and includes the capability to manually time stamp the data file to aid in the 
synchronisation of data with events in the clinical trial, i.e., patient movement or the noting down of 
specific vital readings from the commercial monitors. 
2.3.  Clinical Protocol 
The initial clinical trial was set up to establish whether or not PPG signals can be obtained from 
the tracheal wall, and to assess their suitability in pulse rate measurement and SpO2 estimation. These 
will be compared with the same readings as taken by the commercial monitors, as well as with a 
commercial sensor (Masimo, USA) attached to the ZenPPG system. Figure 2 illustrates the system 
used for the tracheal PPG monitoring. 
Following ethical approval from City London and East NHS Research Ethics Committee, 
London, UK, 10 patients (6 female, 4 male), median age 41.5 years (SD 16.8 years), median weight 
75.5 kg (SD 19.7 kg), were recruited from surgical lists at Bart’s NHS Trust, London UK. Each patient 
was recruited into the study by a GCP (Good Clinical Practice) trained clinical member of the 
investigation team. Each recruit was given an information sheet explaining the nature of the study 
and adequate time to decide (48 h) if they wanted to participate. A consent form was acquired from 
willing recruits and after the induction of anaesthesia an endo-tracheal tube with a pre-attached ET 
sensor was placed into the trachea as per normal intubation procedure. 
Prior to intubation the sensor was checked for operability (sensor attached to ZenPPG and LEDs 
operated by software), then adhered to the tube above the inflatable cuff just past the laryngeal 
guidance markers. The sensor was situated on the inside curve of the tube so that the sensor would 
face anteriorly. Figure 3 shows the adhesion of the sensor on the tube just below the inflatable cuff. 
The tube was then placed by normal intubation procedures with the sensor sitting past the larynx 
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near the subglottis. This was visually confirmed by the Anaesthetist. The sensor was switched on 
once the patient was on the operating table and in a secure position. 
 
Figure 2. A system diagram of the tracheal PPG monitoring set-up. (a) The cable connecting to the ET 
sensor. (b) The reference peripheral PPG sensor and cable, which was placed on either the finger or 
toe of the patient, depending on where the commercial sensor was placed. (c) The patient. (d) The 
cable connecting the Zen instrumentation and data acquisition device to the laptop computer. (e) The 
laptop computer containing the data-logging and signal visualisation software. 
 
Figure 3. The ET Sensor attached to a standard adult size 7 ET Tube. 
Recordings commenced from a time when adjustments to LED intensities were made so that 
PPG signals from the ET sensor could be observed on the laptop display from both the infrared and 
red channels. Recordings were complimented with manually-entered time markers that were taken 
approximately every minute. Each marker was accompanied by an SpO2 and pulse rate reading from 
the clinical monitors for comparison during data analysis. 
Recordings were ceased after approximately 1 h. The ET sensor was detached from the ZenPPG 
but left in situ for the remainder of the surgery. The sensor was removed by the anaesthetist on 
waking the patient as part of the normal surgical protocol. 
3. Results 
The data was analysed offline using MATLAB (The MathWorks, Natick, MA, USA). The clinical 
readings were used in the following comparative analyses. In addition to these clinical readings, PPG 
signals were recorded from a periphery (PER) location using the commercial probe already described. 
All time stamps were synchronised with a reading taken from the commercial monitor used by the 
anaesthetist (Phillips probe and processing module on a Drager Anaesthetic Machine). 
3.1. PPG Analysis 
Good quality PPG signals have been acquired from the trachea of all patients at both 
wavelengths. Signals were visually inspected and the longest section of uninterrupted good quality 
signals were selected for preliminary analysis from each patient. As can be seen in Figure 3 the signals 
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from the ET tube were heavily modulated by ventilator artefact. Considering the location of the 
sensor this was expected and was easily filtered out prior to the main analysis. 
The original raw PPG signals were recorded as a mixed AC + DC signal, where the AC portion 
is the part attributed to the volumetric pulse of the blood in the arteries. The DC portion was used to 
calculate the normalised PPG signal for each wavelength, and also in computing the signal to noise 
ratio (SNR) for each PPG wavelength from the ET sensor and the PER sensor 
Figure 4 shows a typical 40 s trace of normalised PPG signals at both wavelengths from both 
sites, the trachea and the periphery location. 
 
Figure 4. A 40 s sample of normalised PPG signals. For illustrative purposes the DC component, and 
high frequency noise have been filtered out. (a) The red PPG signal from the ET sensor. (b) The 
infrared signal from the ET sensor. (c) The red signal from the periphery sensor. (d) The infrared 
signal from the periphery sensor. It can be seen that all signals show a periodic modulation; this was 
caused by the ventilator and was removed with a high pass filter prior to signal analysis and vital-
sign computations. 
Figures 5 and 6 show the bar-plot of the amplitude analysis from the individual patients for the 
ET sensor and the periphery sensor, respectively. The large variance seen in the ET signals as opposed 
to the PER signals is largely due to the results from patients ET3, ET5 and ET7 who displayed much 
greater AC amplitudes than the other subjects. Interestingly the same patients displayed smaller 
normalised amplitudes at the periphery locations. 
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Figure 5. Amplitude analysis of normalised red (red) and infrared (blue) PPGs from the tracheal tube 
sensor for each patient over the monitoring period. 
 
Figure 6. Amplitude analysis of normalised red (red) and infrared (blue) PPGs from the reference 
periphery sensor for each patient over the monitoring period. 
Calculating the signal to noise ratio (SNR) of the red and infrared signals reveals an average SNR 
value for the red and infrared signals from the ET sensor to be 17.7 dB (STD 10.1 dB) and 23.7 dB 
(STD 9.7 dB), respectively. The SNR from the periphery location was 19.8 dB (STD 9.8 dB) and 27.5 
dB (STD 10.4 dB) for the red and infrared PPGS, respectively. Figure 7 shows a box and whisker plot 
of these values. 
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Figure 7. Signal to noise ratio analysis of the PPG signals from the ET and periphery (PER) sensors. 
3.2. Vital Sign Analysis 
All signals were analysed in 10-s segments at each time stamp (corresponding to a clinical 
reading), and passed through a custom algorithm that calculated pulse rate via a fast-Fourier-
transform method and SpO2 using the method set out in [15] and shown in Equations (1) and (2). 
𝑆𝑝𝑂ଶ = 110 − 25𝑅 (1) 
where: 
𝑅 =
஺஼ೃಶವ ஽஼ೃಶವൗ஺஼಺ೃ ஽஼಺ೃൗ
  (2) 
Equation (1) is a generalised SpO2 formula where R is the ratio of the normalised red and infrared 
AC signal. The normalised signal is simply the ratio of the AC part of the PPG waveform to the DC 
waveform. 
3.2.1. Blood Oxygen Saturation Analysis 
There were a total of 106 clinical observations from the 10 patients. The SpO2 observations have 
been analysed using the Bland–Altman [16] analysis technique and are shown in Figure 8. On average 
the mean difference between the ET sensor and the clinical device is −1.7% (1.96 STD 6.2%). 
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Figure 8. Bland–Altman analysis of SpO2 from the ET sensor vs. the clinical monitor. 
A second Bland–Altman analysis was carried out on the periphery sensor against the clinical 
data for verification purposes, and is presented in Figure 9. The periphery sensor shows a mean 
difference of −0.6% (1.96 STD 2.0%). 
 
Figure 9. Bland–Altman analysis of SpO2 from the periphery sensor vs. the clinical monitor. 
The overall mean blood oxygen saturation value calculated from the ET and PER sensor for each 
patient against the clinical reading is given in Table 1. The clinical measurements were taken from 
the pulse oximeter attached to the commercial device used by the anaesthetist. 
Table 1. The mean SpO2 reading from each patient for the ET, PER and clinical sensors. Standard 
mean, median and standard deviation of the results is shown. 
Patient ET SpO2 %  PER SpO2 % Clinical SpO2 % 
ET 1 96.3 97.9 98.5 
ET 2 97.9 98.0 98.7 
ET 3 95.4 97.8 97.3 
ET 4 97.4 97.8 98.0 
ET 5 97.9 98.1 100.0 
ET 6 97.6 97.8 98.4 
ET 7 97.1 98.1 99.0 
ET 8 97.7 96.9 98.1 
ET 9 95.4 97.9 99.0 
ET 10 97.8 98.2 99.0 
MEAN 97.1 97.8 98.6 
MEDIAN 97.5 97.9 98.6 
STD 1.0 0.4 0.7 
3.2.2. Pulse Rate Analysis 
The same 106 clinical observations made from the 10 patients were also made for the pulse rate 
and have been similarly analysed using the Bland–Altman [15] analysis technique and are shown in 
Figure 10. On average the mean difference between the ET sensor and the clinical device is 0.4 bpm 
(1.96 STD 9.1 bpm). 
Biosensors 2019, 9, 119 9 of 12 
 
Figure 10. Bland–Altman analysis of pulse rate from the ET sensor vs. the clinical monitor. 
A second Bland–Altman analysis was carried out on the periphery sensor against the clinical 
data for verification purposes, and is presented in Figure 11. The periphery sensor shows a mean 
difference of 0.8 bpm (1.96 STD 6.6 bpm). 
 
Figure 11. Bland–Altman analysis of pulse rate from the periphery sensor vs. the clinical monitor. 
Individual results of the pulse rate calculated from the ET and PER sensor for each patient 
against the clinical reading is given in Table 2. Each reading is the mean pulse rate of all time stamps 
calculated for each patient, and was calculated from the infrared PPG signal, since they showed the 
highest SNR at each sensor site. The clinical measurements were taken from the pulse oximeter 
attached to the commercial device used by the anaesthetist. 
Table 2. The mean pulse rate reading from each patient for the ET, PER and Clinical sensors. Standard 
mean, median and standard deviation of the results is shown. 
Patient ET PR (bpm) PER PR (bpm) Clinical PR (BPM) 
ET 1 62.8 64.0 63.0 
ET 2 44.1 44.4 43.4 
ET 3 65.6 65.7 64.2 
ET 4 66.0 66.0 65.3 
ET 5 60.0 60.0 60.4 
ET 6 77.9 78.0 76.5 
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ET 7 76.4 76.4 74.7 
ET 8 68.4 69.0 69.3 
ET 9 73.8 69.6 73.7 
ET 10 58.6 58.6 56.9 
MEAN 65.4 65.2 64.7 
MEDIAN 65.8 65.9 64.7 
STD 10.0 9.6 9.9 
4. Discussion 
The study has shown for the first time the feasibility of acquiring PPGs signals from the human 
trachea. Initial observation of the PPG signals from the tracheal sensor compared to the reference 
sensor at the periphery location reveal that the trachea has overall larger normalised amplitude PPG 
signals compared to the periphery location. This fits with the assumption that the trachea, being at a 
central anatomical location, and close to the supporting network of blood vessels from the heart, 
would have a richer blood supply and be better perfused. However the variance of the PPG signals 
is greater, and the SNR lower. This may suggest that either the trachea is more susceptible to 
variations in blood supply caused by sympathetic responses, or that the sensor itself may not have 
been adequately located during the placement procedure. 
As there was no way to confirm the sensor location after placement, or what the exact orientation 
of the tube was after the patient was moved to the operating table it is our belief that the variance 
issue was due to the later reasoning. It is observed that patients 3, 5, 7 and (to a lesser extent) 6 
exhibited tracheal PPG amplitudes much greater than the corresponding PPG signals from the 
periphery location. This observation may be due to the previous assumption of the blood supply 
being greater and hence the tissue being better perfused or that the sensor was more adequately 
located. Rigorous testing would be needed to test this hypothesis. During sensor placement 
considerable effort was made by the anaesthetist to keep the orientation the same for every patient 
(sensor facing anterior) so that the same tissue was being observed in all patients. The results of the 
SpO2 calculations and corresponding comparative evaluation in Figures 8 and 9 are encouraging for 
the future exploration of utilising the trachea to monitor SpO2 as an alternative to traditional locations 
as the overall difference is less than 2%. The larger than expected standard deviation compared to the 
reference sensor may easily be explained by the previously discussed item of signal amplitude 
variance and low SNR which would alter the ratio of ratios value needed to compute SpO2. 
As mentioned in the methods section reflectance pulse oximeter sensors are normally 
constructed so that the LEDs are equidistant from the detector. Work done with fibre optics [17,18] 
shows optimum separation at 3 to 6mm. Additionally there are also simulated computer models 
confirming that for the wavelengths of 660 nm and 940 nm in a finger model, an ideal separation 
distance <1 cm yields optimal depth of light penetration for SaO2 values >90% [19]. Components 
available at the time of the design of the sensor meant that a compromise had to be made in the 
placement and geometrical arrangement. Acquiring PPGs from the trachea was seen as a priority 
over whether or not this geometry was optimised for pulse oximetry, and the experiment was 
commenced with the compromised design. 
As the physical distance of these components was greater than the suggestion made in the 
literature it can be reasonably concluded that the signals required for SpO2 calculation were not of 
optimum quality. The recent introduction of dedicated pulse oximeter sensors from likes of Osram 
Opto Semiconductors (Regensburg, Germany) (BIOFY Series) does open up new opportunities in 
sensor design, offering miniature one-chip pulse oximeter sensor solutions with optimised 
reflectance component placement, ideal for this type of sensor, and may solve the issue discussed. 
Calculating pulse rate from the AC component of a PPG signal is a common and well established 
method of determining heart rate in patients. The pulse rate seen at the trachea varied by less than 
one beat compared to the periphery sensor and the commercial monitor. The standard deviation seen 
across individual patients shown in Table 2 was only varied due the fact that the heart rate naturally 
has a large range between individuals. However, the standard deviation between the three different 
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monitoring sites has little variation, and can be considered negligible since heart rate is only ever 
reported in whole integer values. The Bland–Altman analysis shows a relatively high variance, but 
on careful inspection of the timestamps gathered in the trial there are a small number of pulse rate 
calculation errors where the algorithm was not able to detect the pulse rate frequency needed for 
pulse rate estimation. A subsequent inspection of the signals involved shows some movement 
artefact at some of these points and for others the signal has some high frequency interference, 
causing an under or overestimation in HR, respectively. 
5. Conclusions 
In this study it has been shown that good quality photoplethysmographic (PPG) signals can be 
measured in the human trachea. Simultaneous infrared PPG signals from identical reflectance probes 
in the trachea and on a finger were recorded and compared. On the basis of the data obtained, we 
conclude that the trachea PPG signals are of good quality with relatively good signal to noise ratio. 
The close agreement between the calculated values of arterial blood oxygen saturation in the 
trachea and the commercial oximeter values support the hypothesis that the trachea may be an 
effective alternative site for monitoring blood oxygen saturation. Further studies are needed to 
establish whether the trachea can be used for monitoring blood oxygen saturation in patients with 
poor periphery circulation in whom conventional pulse oximetry fails. 
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